About the Editors
Steven R. Steinhubl, M.D.
Director, Digital Medicine, Scripps Translational Science Institute
Professor of Genomics, The Scripps Research Institute
Cardiologist, Scripps Clinic
Prior to joining Scripps, Dr. Steinhubl was the Director of Cardiovascular Wellness and the Medical Director for Employee Wellness for the Geisinger Healthcare System. Previously, he was a Global Medical Vice-President for the Medicines Company, and the Director of Cardiovascular Education and Clinical Research at the University of Kentucky in Lexington. Dr. Steinhubl’s research activities have covered a broad range of topics in cardiology, with a primary early focus on trials of novel antithrombotic therapies for the treatment and prevention of cardiovascular disease, and more recently on the application of an integrated systems-based approach to the optimal identification, communication, and treatment of an individual’s risk for various manifestations of cardiovascular disease. He has been principal investigator or helped lead over a dozen large-scale, international randomized trials. He has also written nearly 200 peer-reviewed manuscripts as well as numerous book chapters and abstracts.
Eric Topol, MD
Executive VP, The Scripps Research Institutes
Founder and Director, Scripps Translational Science Institute
Professor, Molecular Medicine
Voted Most Influential Physician Executive in the US in Modern Healthcare's 2012 poll, Dr. Topol is a practicing cardiologist at Scripps in La Jolla, California, and is widely credited for Cleveland Clinic's status as the leading center for heart care. There, he started a medical school; led worldwide clinical trials to advance care for heart disease, and spearheaded the discovery of genes that increase susceptibility for heart attacks. Since 2006, in La Jolla, he leads the flagship NIH supported Scripps Translational Science Institute and is a co-Founder of the West Wireless Health Institute. His research focus is on individualized medicine, using the genome and digital technologies to understand each person at the biologic, physiologic granular level to determine appropriate therapies and prevention. He has pioneered the development of many medications that are routinely used in medical practice including t-PA, Plavix, Angiomax, and ReoPro and was the first physician to raise safety concerns on Vioxx. He has published 1100 peer-reviewed articles and over 30 medical textbooks.
Hugh Harvey, MBBS BSc(Hons) FRCR MD(Res)
Clinical Lead, Kheiron Medical
Dr Harvey is a board-certified consultant radiologist and academic, trained in the NHS and Europe’s leading cancer research center, the Institute of Cancer Research, where he completed his MD research degree in prostate MR volumetry and was twice awarded ICR Science Writer of the Year. He then led the regulatory affairs team at Babylon Health, the UK's largest digital health start-up, successfully gaining the world-first CE marking for an AI-supported triage service, before becoming a consultant radiologist at Guys and St Thomas Hospital in London. He is a UK Royal College of Radiologists informatics committee member, advisor to the NHS on AI, and is board advisor to several AI start-up companies across the globe.
Santosh Kumar, PhD
Director, NIH Center of Excellence for Mobile Sensor Data-to-Knowledge (MD2K)
Professor and Lillian & Morrie Moss Chair of Excellence
The University of Memphis
Santosh Kumar's research focusses on mobile health (or mHealth). He and his students have developed computational models to infer human health and behavior such as stress, conversation, smoking, craving, and cocaine use from wearable sensor data. He leads several large multidisciplinary projects in mHealth funded by National Institutes of Health (NIH) and National Science Foundation (NSF). He currently leads NIH-funded national Center of Excellence on Mobile Sensor Data-to-Knowledge (MD2K), and was named one of America’s ten most brilliant scientists under the age of 38 by Popular Science in 2010, and Tennessee’s first chair of excellence in Computer Science (2015).
Evan D. Muse, M.D., Ph.D., M.C.T.I.
Assistant Professor, Scripps Translational Science Institute
Cardiologist, Scripps Clinic
Evan D. Muse, M.D., Ph.D., M.C.T.I., is a physician-scientist with research interests that mine the transition zone of digital medicine, genomics and cardiovascular disease. In addition to his clinical practice, he conducts research exploring the crosstalk of lipid and inflammatory networks in macrophage, with the goal of identifying new therapies for the prevention and treatment of atherosclerotic heart disease (atherosclerosis). He also conducts clinical trials in the genomics of cardiovascular diseases, including atrial fibrillation and heart attack. He joined STSI as a KL2 Scholar in 2012 and received a Master of Science in Clinical Investigation at The Scripps Research Institute.
John A. Rogers, PhD
Professor, McCormick School of Engineering and Neurological Surgery
Professor John A. Rogers' research seeks to understand and exploit interesting characteristics of 'soft' materials, such as polymers, liquid crystals, and biological tissues as well as hybrid combinations of them with unusual classes of micro/nanomaterials, in the form of ribbons, wires, membranes, tubes or related. Current research focuses on soft materials for conformal electronics, nanophotonic structures, microfluidic devices, and microelectromechanical systems, all lately with an emphasis on bio-inspired and bio-integrated technologies. These efforts are highly multidisciplinary, and combine expertise from nearly every traditional field of technical study.His work has been recognized by many awards including the Lemelson-MIT Prize (2011), and the Smithsonian Award for American Ingenuity in the Physical Sciences (2013).
Aenor J. Sawyer, MD, MS
Director UCSF Skeletal Health Service, Health Innovation & Technology, Orthopaedics
Asst. Clinical Professor, Dept. Orthopaedic Surgery
University of California San Francisco
Dr. Aenor Sawyer is an expert in physical therapy and exercise physiology and provides comprehensive musculoskeletal care to pediatric and adolescent orthopedic patients. Her research interests include sports injury prevention, anterior cruciate ligament (ACL) repair and osteoporosis. Dr. Sawyer has more than a decade of health technology experience in development of device and digital health solutions, telemedicine and emergency medical response (EMR) design and implementation. She currently guides development, evaluation and translation of novel technologies at UCSF and external incubators. She also founded and directs the UCSF Skeletal Health Service which provides bone health care across the lifespan.
Donna Spruijt-Metz, MFA, PhD
Director USC-CESR Mobile and Connected Health Program
USC Center for Economic and Social Research
University of Southern California
Dr. Spruijt-Metz's research focuses on childhood obesity and mobile health technologies, and she works predominantly with minority populations. Her main interests include using mobile technologies to develop data sets that combine sensor and self-report data that is temporally rich and highly contextualized. Current projects include the Monitoring & Modeling Family Eating Dynamics (M2FED) project, funded by the National Science Foundation (NSF). Her work meshes 21st century technologies with transdisciplinary metabolic, behavioral and environmental research in order to facilitate the development of dynamic, personalized, contextualized behavioral interventions that can be adapted on the fly.
John B. Torous, M.D.
Co-director of the Digital Psychiatry Program
Beth Israel Deaconess Medical Center
Harvard Medical School
Dr. Torous is a board certified psychiatrist with a background in electrical engineering and computer sciences and enjoys exploring digital mental health. Dr. Torous is active in investigating the potential of mobile mental health technologies for psychiatry, developing smartphone tools for clinical research, leading clinical studies of smartphone apps for diverse mental illnesses, and publishing on the research, ethical, and patient perspectives of digital psychiatry. He currently leads the American Psychiatric Association’s work group on the evaluation of smartphone apps, and co-chairs the Massachusetts Psychiatric Society's Health Information Technology Committee.
Jill Waalen, MD, MS, MPH
Department of Molecular Medicine
The Scripps Research Institute
In addtion to her role at TSRI, Dr. Jill Waalen is also a Lecturer for Seminar in Preventive Medicine, and serves as Associate Director of the University of California San Diego-San Diego State University General Preventive Medicine Residency Program. She joined STSI in Nov. 2010 as a Biostatistician, and continues her research at TSRI while providing biostatistics expertise to STSI investigators. Dr. Waalen also serves as director for several biostatistics courses focused on equipping scientists with the statistical knowledge and programming skills for enhanced analysis of their own data. She plans to continue her research at TSRI while providing biostatistics expertise to STSI investigators. In addition, she is the author or co-author of over 45 journal articles, focusing on the genetic epidemiology of hematologic diseases.
Robyn Whittaker, MD
Associate Director, Co-leader Health Informatics & Technology
National Institue for Health Innovation
University of Auckland
Auckland, New Zealand
Dr. Robyn Whittaker is currently leading the innovation stream within a newly established Institute for Innovation and Improvement at Waitemata District Health Board. She leads the Leapfrog Programme of enterprise wide strategic projects, partnerships with industry and academic institutions, and a Centre for Health IT & Creative Design. Her research interests are in mHealth, including health behaviour change interventions, and self-management programmes for long term conditions. Robyn contributes to several national and international groups including the WHO/ International Telecommunications Union’s Informal Expert Groups, and the board of the NZ Health Innovation Hub, among others.